Antimicrobial resistance (AMR) presents a substantial global menace, diminishing the effectiveness of antibiotics and posing challenges to combat bacterial infections. The excessive use of antibiotics accelerates the emergence of drug-resistant pathogens, resulting in prolonged illnesses, elevated mortality rates, and escalated healthcare expenditures. Consequently, there is a drive to explore novel solutions to address this pressing concerns. Nanotechnology, gene technology, and molecular diagnostics are being developed as innovative strategies to tackle AMR. These approaches enable precise drug delivery, genetic modifications, and rapid detection of drug-resistant strains. This review examines these advanced technologies, highlighting their potential in AMR management and advocating for a comprehensive approach.
No takes yet. Share an insight, caveat, or question.
Jiayang Qiu (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: